查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1961079

数位医药供应链管理市场－全球产业规模、份额、趋势、机会、预测：按产品、交付模式、软体模组、地区和竞争对手划分，2021-2031年

Digital Pharmaceutical Supply Chain Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Mode of Delivery, By Software Modules, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球数位医药供应链管理市场预计将从 2025 年的 9.5001 亿美元成长到 2031 年的 14.0268 亿美元，复合年增长率为 6.71%。

在这一领域，物联网 (IoT)、区块链和人工智慧 (AI) 等技术被整合起来，用于管理从生产到交付的药品物流，确保即时可视性和产品完整性。推动成长的关键因素包括严格的监管要求，例如对追踪和溯源合规性的要求，以及对温度敏感生物製药维持低温运输的迫切需求。此外，降低营运成本和消除供应链中的假药也是推动产业发展的重要因素，使得这些先进的数位化解决方案对于确保病患安全和提高效率至关重要。

市场概览
预测期 2027-2031
市场规模：2025年 950,010,000 美元
市场规模：2031年 14.0268亿美元
复合年增长率：2026-2031年 6.71%
成长最快的细分市场 软体
最大的市场 北美洲

然而，市场成长常常受到高昂的实施成本以及将现代数位工具与现有传统基础设施整合困难的限制，导致互通性方面存在重大挑战。儘管存在这些障碍，但该领域仍在不断努力推进技术进步，以应对日益增长的业务量和复杂性。根据医疗保健分销联盟研究基金会（Healthcare Distribution Alliance Research Foundation）预测，到2024年，68%的药品分销公司将采用自动化方法，一半的发票将透过这些数位化系统处理。这项数据表明，企业越来越依赖数位自动化来支援业务流程。

市场驱动因素

为缓解全球药品短缺，对具有韧性的供应链的需求是推动数位化管理系统普及的主要动力。儘管面临物流中断和原材料短缺，但确保患者照护的连续性仍然至关重要，这促使相关人员实施即时监控和预测分析，以识别薄弱环节并高效管理存量基准。根据美国卫生系统药剂师协会于2024年4月发布的《全国药品短缺统计数据》，2024年第一季药品短缺数量达到创纪录的323种，凸显了强大的数位化监控对于应对这些供应缺口的重要性。

随着假药氾滥日益严重，采用先进的认证技术来保障药品的完整性变得愈发必要。製药公司正利用序列化工具和区块链技术来保护从生产到终端用户的整个控制链，并检验药品的真伪，从而确保患者获得正品药品，并维护公众健康。根据製药安全研究所 (PSI) 2024 年 6 月发布的《2023 年现况报告》，该研究所记录了 2023 年发生的 6,659 起药品犯罪案件，显示药品犯罪构成持续威胁，而数位追踪技术必须应对这一威胁。这种以安全为中心的策略与更广泛的投资趋势相符。根据三菱重工 (MHI) 2024 年的调查，55% 的供应链经理表示将增加对供应链技术和创新的投资，这反映出全国对数位转型的重视。

市场挑战

将现有传统基础设施与现代数位工具整合是全球数位化医药供应链管理市场扩张的一大障碍。医药行业的许多相关人员仍然依赖分散且过时的系统，这些系统缺乏与人工智慧驱动的分析和区块链等先进平台无缝整合的柔软性。这种互通性差距造成了资料孤岛，将关键的医药物流资讯困在孤立的部门中，阻碍了高效运作所需的全面、即时可视性。因此，企业在尝试维修这些传统系统时会面临严重的延误和增加的财务负担，直接阻碍了全面数位化供应链解决方案的普及。

这些技术壁垒的影响也反映在近期产业关于营运透明度的数据中。据GS1美国公司称，到2025年，约43%的供应链专业人士表示难以维持全面的营运可视性，这凸显了在整个网路中充分利用标准化数位资料的现状依然存在。这种透明度的缺失不仅削弱了数位化带来的效率提升，也使企业难以满足严格的可追溯性要求。只要这些整合难题持续存在，市场充分实现自动化和产品完整性提升所带来的益处的能力就将受到限制。

市场趋势

将数位双胞胎技术引入供应链仿真，使製药公司能够从静态分析转向动态虚拟场景规划，从而製定更有效的物流策略。透过产生实体供应链的精确虚拟副本，相关人员可以模拟潜在中断的影响，测试新的配送路线，并在不影响实际库存的情况下检验流程变更。这项功能在优化复杂的网路设计方面尤其重要，因为实体试验极为高成本。根据Hexagon于2025年3月发布的《製药製造转型》报告，只有17%的公司表示目前正在使用其设施的数位双胞胎，而79%的公司正在新计画中利用该技术来加强协作并提高设计精度。

同时，人工智慧 (AI) 在预测分析和需求预测方面的应用，正透过优先提升商业效率和减少废弃物，变革库存管理。与传统的被动式模型不同，这些先进的演算法能够分析大量的历史数据和即时数据，从而预测市场消费模式。这确保了对温度敏感的生物製药能够妥善保管，最大限度地降低过期风险。这一趋势正透过自动化决策，推动实际的投资回报 (ROI)，其重点在于优化营运资本和服务水准之间的平衡。根据 LogiPharma 发布的《2024 年 LogiPharma AI 报告》（2024 年 11 月），40% 的医药供应链领导者目前正优先考虑采用 AI 技术进行需求预测和减少废弃物，这标誌着企业正朝着数据驱动的营运效率方向迈出重要一步。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球数位化医药供应链管理市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品（软体、硬体）分类
    • 交付方式（本地部署、云端部署、Web部署）
    • 软体模组（计划与分析、采购、製造、物流、库存管理）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美数位化医药供应链管理市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲数位化医药供应链管理市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区数位化医药供应链管理市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲数位化医药供应链管理市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲数位化医药供应链管理市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球数位化医药供应链管理市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • McKesson Corporation
  • Mediceo Corporation
  • Palantir Technologies, Inc.
  • InterSystems Corporation
  • Tecsys Inc.
  • Oracle Corporation
  • SAP SE
  • Infor Inc.
  • CenTrak, Inc.（HALMA plc）
  • Terso Solutions, Inc.（Promega Corporation）

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 23401

The Global Digital Pharmaceutical Supply Chain Management Market is projected to expand from USD 950.01 Million in 2025 to USD 1402.68 Million by 2031, registering a CAGR of 6.71%. This sector integrates technologies such as the Internet of Things, blockchain, and artificial intelligence to oversee medication logistics from manufacturing through delivery, ensuring real-time visibility and product integrity. Growth is primarily driven by strict regulatory mandates for track-and-trace compliance and the critical requirement to maintain cold chains for temperature-sensitive biologics. Additionally, the industry is motivated by the need to lower operational costs and eradicate counterfeit drugs from the supply network, necessitating these advanced digital solutions to guarantee patient safety and efficiency.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 950.01 Million
Market Size 2031USD 1402.68 Million
CAGR 2026-20316.71%
Fastest Growing SegmentSoftware
Largest MarketNorth America

However, market growth is frequently hindered by high deployment costs and the difficulty of merging modern digital tools with existing legacy infrastructures, which results in significant interoperability challenges. Despite these obstacles, the sector remains committed to technological advancement to manage increasing volume and complexity. According to the Healthcare Distribution Alliance Research Foundation, in 2024, 68 percent of pharmaceutical distribution companies reported using automated methods, with half of all invoice lines processed through these digitized systems. This statistic highlights the increasing reliance on digital automation to support operational workflows.

Market Driver

The demand for resilient supply chains to mitigate global drug shortages serves as a major catalyst for the adoption of digital management systems. Industry stakeholders are implementing real-time monitoring and predictive analytics to spot vulnerabilities and efficiently manage inventory levels, driven by the urgent need to ensure continuity in patient care despite logistical disruptions and raw material scarcity. According to the American Society of Health-System Pharmacists, April 2024, in the 'National Drug Shortages Statistics', active drug shortages hit a record high of 323 in the first quarter of 2024, emphasizing the critical necessity for robust digital oversight to navigate these supply gaps.

The increasing prevalence of counterfeit drugs further necessitates advanced authentication technologies to guarantee product integrity. Pharmaceutical entities employ serialization tools and blockchain to secure the chain of custody and verify authenticity from production to the end user, ensuring patients receive genuine medications and protecting public health. According to the Pharmaceutical Security Institute, June 2024, in the '2023 Situation Report', the organization recorded 6,659 pharmaceutical crime incidents in 2023, representing a persistent threat that digital tracking seeks to neutralize. This security focus aligns with broader investment trends; according to MHI, in 2024, 55 percent of supply chain leaders reported increasing their financial investment in supply chain technology and innovation, reflecting an industry-wide commitment to digital transformation.

Market Challenge

The integration of modern digital tools with existing legacy infrastructures poses a significant barrier to the expansion of the Global Digital Pharmaceutical Supply Chain Management Market. Many stakeholders in the pharmaceutical industry continue to rely on fragmented, older systems that lack the flexibility to communicate seamlessly with advanced platforms such as AI-driven analytics or blockchain. This interoperability gap creates data silos where critical medication logistics information becomes trapped within isolated departments, preventing the holistic, real-time visibility necessary for efficient operations. Consequently, companies encounter significant delays and increased financial burdens when attempting to retrofit these archaic structures, which directly curbs the adoption rate of comprehensive digital supply chain solutions.

The impact of these technological hurdles is reflected in recent industry data concerning operational transparency. According to GS1 US, in 2025, nearly 43 percent of supply chain professionals reported struggling to maintain full visibility into their operations, highlighting a persistent inability to fully leverage standardized digital data across the network. This lack of transparency not only undermines the efficiency gains promised by digitization but also complicates compliance with rigorous track-and-trace mandates. As long as these integration complexities persist, the market's ability to fully realize the benefits of automation and enhanced product integrity will remain constrained.

Market Trends

The adoption of Digital Twin Technology for Supply Chain Simulation allows pharmaceutical companies to strategize logistics by transitioning from static analysis to dynamic, virtual scenario planning. By generating exact virtual replicas of the physical supply chain, stakeholders can simulate the impact of potential disruptions, test new distribution routes, and validate process changes without risking actual inventory. This capability is particularly vital for optimizing complex network designs where physical trial-and-error is prohibitively expensive. According to Hexagon, March 2025, in the 'Transforming Pharmaceutical Manufacturing' report, while only 17 percent of respondents reported currently using a digital twin of their facilities, 79 percent are now leveraging the technology for new projects to enhance collaboration and design precision.

Simultaneously, the integration of Artificial Intelligence for Predictive Analytics and Demand Forecasting is reshaping inventory management by prioritizing commercial efficiency and waste reduction. Unlike traditional reactive models, these advanced algorithms analyze vast historical and real-time datasets to predict market consumption patterns, ensuring that temperature-sensitive biologics are positioned to minimize expiration risks. This trend focuses heavily on optimizing the balance between working capital and service levels, driving tangible returns on investment through automated decision-making. According to LogiPharma, November 2024, in the '2024 LogiPharma AI Report', 40 percent of pharmaceutical supply chain leaders are now prioritizing AI specifically for demand forecasting and minimizing waste, marking a decisive move towards data-driven operational excellence.

Key Market Players

  • McKesson Corporation
  • Mediceo Corporation
  • Palantir Technologies, Inc.
  • InterSystems Corporation
  • Tecsys Inc.
  • Oracle Corporation
  • SAP SE
  • Infor Inc.
  • CenTrak, Inc. (HALMA plc)
  • Terso Solutions, Inc. (Promega Corporation)

Report Scope

In this report, the Global Digital Pharmaceutical Supply Chain Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Pharmaceutical Supply Chain Management Market, By Product

  • Software
  • Hardware

Digital Pharmaceutical Supply Chain Management Market, By Mode of Delivery

  • On-premises
  • Cloud-based
  • Web-based

Digital Pharmaceutical Supply Chain Management Market, By Software Modules

  • Planning & Analytics
  • Procurement
  • Manufacturing
  • Logistics
  • Inventory management

Digital Pharmaceutical Supply Chain Management Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Pharmaceutical Supply Chain Management Market.

Available Customizations:

Global Digital Pharmaceutical Supply Chain Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Pharmaceutical Supply Chain Management Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Software, Hardware)
    • 5.2.2. By Mode of Delivery (On-premises, Cloud-based, Web-based)
    • 5.2.3. By Software Modules (Planning & Analytics, Procurement, Manufacturing, Logistics, Inventory management)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Digital Pharmaceutical Supply Chain Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Mode of Delivery
    • 6.2.3. By Software Modules
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Pharmaceutical Supply Chain Management Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Mode of Delivery
        • 6.3.1.2.3. By Software Modules
    • 6.3.2. Canada Digital Pharmaceutical Supply Chain Management Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Mode of Delivery
        • 6.3.2.2.3. By Software Modules
    • 6.3.3. Mexico Digital Pharmaceutical Supply Chain Management Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Mode of Delivery
        • 6.3.3.2.3. By Software Modules

7. Europe Digital Pharmaceutical Supply Chain Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Mode of Delivery
    • 7.2.3. By Software Modules
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Pharmaceutical Supply Chain Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Mode of Delivery
        • 7.3.1.2.3. By Software Modules
    • 7.3.2. France Digital Pharmaceutical Supply Chain Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Mode of Delivery
        • 7.3.2.2.3. By Software Modules
    • 7.3.3. United Kingdom Digital Pharmaceutical Supply Chain Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Mode of Delivery
        • 7.3.3.2.3. By Software Modules
    • 7.3.4. Italy Digital Pharmaceutical Supply Chain Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Mode of Delivery
        • 7.3.4.2.3. By Software Modules
    • 7.3.5. Spain Digital Pharmaceutical Supply Chain Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Mode of Delivery
        • 7.3.5.2.3. By Software Modules

8. Asia Pacific Digital Pharmaceutical Supply Chain Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Mode of Delivery
    • 8.2.3. By Software Modules
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Digital Pharmaceutical Supply Chain Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Mode of Delivery
        • 8.3.1.2.3. By Software Modules
    • 8.3.2. India Digital Pharmaceutical Supply Chain Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Mode of Delivery
        • 8.3.2.2.3. By Software Modules
    • 8.3.3. Japan Digital Pharmaceutical Supply Chain Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Mode of Delivery
        • 8.3.3.2.3. By Software Modules
    • 8.3.4. South Korea Digital Pharmaceutical Supply Chain Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Mode of Delivery
        • 8.3.4.2.3. By Software Modules
    • 8.3.5. Australia Digital Pharmaceutical Supply Chain Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Mode of Delivery
        • 8.3.5.2.3. By Software Modules

9. Middle East & Africa Digital Pharmaceutical Supply Chain Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Mode of Delivery
    • 9.2.3. By Software Modules
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Digital Pharmaceutical Supply Chain Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Mode of Delivery
        • 9.3.1.2.3. By Software Modules
    • 9.3.2. UAE Digital Pharmaceutical Supply Chain Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Mode of Delivery
        • 9.3.2.2.3. By Software Modules
    • 9.3.3. South Africa Digital Pharmaceutical Supply Chain Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Mode of Delivery
        • 9.3.3.2.3. By Software Modules

10. South America Digital Pharmaceutical Supply Chain Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Mode of Delivery
    • 10.2.3. By Software Modules
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Digital Pharmaceutical Supply Chain Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Mode of Delivery
        • 10.3.1.2.3. By Software Modules
    • 10.3.2. Colombia Digital Pharmaceutical Supply Chain Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Mode of Delivery
        • 10.3.2.2.3. By Software Modules
    • 10.3.3. Argentina Digital Pharmaceutical Supply Chain Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Mode of Delivery
        • 10.3.3.2.3. By Software Modules

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Digital Pharmaceutical Supply Chain Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. McKesson Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Mediceo Corporation
  • 15.3. Palantir Technologies, Inc.
  • 15.4. InterSystems Corporation
  • 15.5. Tecsys Inc.
  • 15.6. Oracle Corporation
  • 15.7. SAP SE
  • 15.8. Infor Inc.
  • 15.9. CenTrak, Inc. (HALMA plc)
  • 15.10. Terso Solutions, Inc. (Promega Corporation)

16. Strategic Recommendations

17. About Us & Disclaimer